UK authorises gene therapy for blood disorders in world first
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston, Massachusetts, U.S., October 23, 2019. REUTERS/Brian Snyder Acquire Licensing Rights LONDON, Nov 16 (Reuters) - Britain has authorised a gene therapy that aims to cure sickle-cell disease and another type of…
#boston #massachusetts #nobelprize #medicinesand #healthcare #julianbeach #mhra #crisprtherapeutics #thisnobelprize #samarthkulkarni